MEDICENNA THERAPEUTICS CORP. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.42 CAD | -1.22% |
|
-12.64% | +476.19% |
| 05-13 | Medicenna Says ABILITY-1 Abstract Withdrawn by ASCO Program Committee | MT |
| 05-13 | Medicenna Brief: Providing Update on its Presentations at the 2024 ASCO Annual Meeting | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Other Biotechnology & Medical Research | -1.22% | -12.64% | +476.19% | +171.91% | +261.19% | 135M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- MDNA Stock
- Charts Medicenna Therapeutics Corp.
- Comparison Chart